(a)
In general— The Secretary of Defense, in coordination with Secretary of Veterans Affairs, shall evaluate—
(1)
the results of research, conducted by either such Secretary, related to menopause, perimenopause, or mid-life women’s health that is complete;
(2)
the status of such research that is ongoing; and
(3)
any gaps in knowledge and research on—
(A)
treatments for menopause-related symptoms;
(B)
the safety and effectiveness of treatments for menopause-related symptoms;
(C)
the relation to and impact of military service to perimenopause and menopause;
(D)
the effect of combat roles on perimenopause and menopause-related symptoms, including exposure to burn pits, toxic chemicals, and perfluoroalkyl and polyfluoroalkyl substances (commonly known as “PFAS”); and
(E)
the impact perimenopause and menopause has on the mental health of women who are members of the Armed Forces or veterans.
(b)
Report; strategic plan— Not later than 180 days after the date of the enactment of this Act, each Secretary shall submit to Congress—
(1)
a report on the findings of such evaluation; and
(2)
a strategic plan that—
(A)
resolves the gaps in knowledge and research identified in such report; and
(B)
identifies topics in need of further research relating to potential treatments for menopause-related symptoms of women who are members of the Armed Forces or veterans.